Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like What IoT Can Do for You: Looking Forward May 9, 2019 AntWorks introduces ANTstein SQUARE integrated automation platform May 1, 2019 Steam-powered Steam Trap Monitors: Should Someone Have Thought of This Before? September 18, 2018